Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-032172
Filing Date
2016-10-21
Accepted
2016-10-21 17:23:54
Documents
1
Period of Report
2016-10-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 13886
  Complete submission text file 0000899243-16-032172.txt   15334
Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1 650-615-2119
Prothena Corp plc (Issuer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROTHENA CORPORATION PLC 650 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Kinney Gene G. (Reporting) CIK: 0001564380 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35676 | Film No.: 161946858